Skyrizi
Risankizumab-rzaa · KIT · AbbVie Inc.
No Recall History
Plain English
Skyrizi is a kit containing risankizumab-rzaa. Manufactured by AbbVie Inc..
Key Facts
- Brand Name
- Skyrizi
- Generic Name
- Risankizumab-rzaa
- NDC Code (Product)
0074-7042- Manufacturer
- AbbVie Inc.
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA761105
- Drug Class
- Interleukin-23 Antagonist [EPC]
- Marketing Start
- 03/04/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is Skyrizi used for?
Skyrizi contains Risankizumab-rzaa. It is a kit taken as directed. Consult your doctor for specific uses.
Is Skyrizi a controlled substance?
Skyrizi is not classified as a controlled substance by the DEA.
What is the generic name for Skyrizi?
The generic name for Skyrizi is Risankizumab-rzaa. There are no other listed brand versions of Risankizumab-rzaa.
What is the NDC code for Skyrizi ?
The NDC (National Drug Code) for Skyrizi is 0074-7042, listed by AbbVie Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)